vs
Orthofix Medical Inc.（OFIX）与Offerpad Solutions Inc.（OPAD）财务数据对比。点击上方公司名可切换其他公司
Orthofix Medical Inc.的季度营收约是Offerpad Solutions Inc.的1.9倍（$219.9M vs $114.1M），Orthofix Medical Inc.同比增速更快（2.0% vs -34.5%），Offerpad Solutions Inc.自由现金流更多（$65.7M vs $16.8M），过去两年Orthofix Medical Inc.的营收复合增速更高（8.0% vs -36.8%）
Orthofix医疗是全球知名骨科医疗器械企业，专注于研发、生产及销售脊柱植入物、骨科创伤产品、骨生长刺激治疗设备及再生医疗产品，服务全球多地的骨科医师与医疗机构，致力于提升肌肉骨骼疾病患者的诊疗效果。
Offerpad Solutions Inc是美国知名房地产科技企业，专注于简化住宅房产交易流程，采用iBuyer模式直接向卖家收购房屋，完成翻新后挂牌出售，同时提供按揭、产权服务、灵活搬迁方案等配套服务，业务覆盖美国数十个州。
OFIX vs OPAD — 直观对比
营收规模更大
OFIX
是对方的1.9倍
$114.1M
营收增速更快
OFIX
高出36.5%
-34.5%
自由现金流更多
OPAD
多$48.9M
$16.8M
两年增速更快
OFIX
近两年复合增速
-36.8%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $219.9M | $114.1M |
| 净利润 | $-2.2M | — |
| 毛利率 | 71.1% | 7.0% |
| 营业利润率 | 0.2% | — |
| 净利率 | -1.0% | — |
| 营收同比 | 2.0% | -34.5% |
| 净利润同比 | 92.4% | 49.1% |
| 每股收益（稀释后） | $-0.05 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收OFIXOPAD
| Q4 25 | $219.9M | $114.1M | ||
| Q3 25 | $205.6M | $132.7M | ||
| Q2 25 | $203.1M | $160.3M | ||
| Q1 25 | $193.6M | $160.7M | ||
| Q4 24 | $215.7M | $174.3M | ||
| Q3 24 | $196.6M | $208.1M | ||
| Q2 24 | $198.6M | $251.1M | ||
| Q1 24 | $188.6M | $285.4M |
净利润OFIXOPAD
| Q4 25 | $-2.2M | — | ||
| Q3 25 | $-22.8M | $-11.6M | ||
| Q2 25 | $-14.1M | $-10.9M | ||
| Q1 25 | $-53.1M | $-15.1M | ||
| Q4 24 | $-29.1M | $-17.3M | ||
| Q3 24 | $-27.4M | $-13.5M | ||
| Q2 24 | $-33.4M | $-13.8M | ||
| Q1 24 | $-36.0M | $-17.5M |
毛利率OFIXOPAD
| Q4 25 | 71.1% | 7.0% | ||
| Q3 25 | 72.2% | 7.0% | ||
| Q2 25 | 68.7% | 8.9% | ||
| Q1 25 | 62.8% | 6.5% | ||
| Q4 24 | 69.0% | 6.1% | ||
| Q3 24 | 68.7% | 8.2% | ||
| Q2 24 | 67.8% | 8.7% | ||
| Q1 24 | 67.5% | 7.9% |
营业利润率OFIXOPAD
| Q4 25 | 0.2% | — | ||
| Q3 25 | -8.3% | -5.1% | ||
| Q2 25 | -7.9% | -4.9% | ||
| Q1 25 | -25.2% | -7.2% | ||
| Q4 24 | -5.3% | -7.8% | ||
| Q3 24 | -9.6% | -4.3% | ||
| Q2 24 | -12.5% | -3.9% | ||
| Q1 24 | -15.6% | -4.8% |
净利率OFIXOPAD
| Q4 25 | -1.0% | — | ||
| Q3 25 | -11.1% | -8.7% | ||
| Q2 25 | -6.9% | -6.8% | ||
| Q1 25 | -27.4% | -9.4% | ||
| Q4 24 | -13.5% | -9.9% | ||
| Q3 24 | -13.9% | -6.5% | ||
| Q2 24 | -16.8% | -5.5% | ||
| Q1 24 | -19.1% | -6.1% |
每股收益（稀释后）OFIXOPAD
| Q4 25 | $-0.05 | — | ||
| Q3 25 | $-0.57 | $-0.37 | ||
| Q2 25 | $-0.36 | $-0.39 | ||
| Q1 25 | $-1.35 | $-0.55 | ||
| Q4 24 | $-0.76 | $-0.64 | ||
| Q3 24 | $-0.71 | $-0.49 | ||
| Q2 24 | $-0.88 | $-0.50 | ||
| Q1 24 | $-0.95 | $-0.64 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $82.0M | $26.5M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $450.0M | $38.2M |
| 总资产 | $850.6M | $154.8M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资OFIXOPAD
| Q4 25 | $82.0M | $26.5M | ||
| Q3 25 | $62.9M | $31.0M | ||
| Q2 25 | $65.6M | $22.6M | ||
| Q1 25 | $58.0M | $30.8M | ||
| Q4 24 | $83.2M | $43.0M | ||
| Q3 24 | $30.1M | $48.5M | ||
| Q2 24 | $26.4M | $56.9M | ||
| Q1 24 | $27.0M | $68.5M |
总债务OFIXOPAD
| Q4 25 | — | — | ||
| Q3 25 | $157.2M | — | ||
| Q2 25 | $157.0M | — | ||
| Q1 25 | $156.9M | — | ||
| Q4 24 | $157.0M | — | ||
| Q3 24 | $118.5M | — | ||
| Q2 24 | $118.0M | — | ||
| Q1 24 | $118.2M | — |
股东权益OFIXOPAD
| Q4 25 | $450.0M | $38.2M | ||
| Q3 25 | $442.5M | $39.9M | ||
| Q2 25 | $458.3M | $24.5M | ||
| Q1 25 | $458.3M | $34.2M | ||
| Q4 24 | $503.1M | $47.7M | ||
| Q3 24 | $525.9M | $64.7M | ||
| Q2 24 | $546.0M | $77.6M | ||
| Q1 24 | $570.3M | $88.1M |
总资产OFIXOPAD
| Q4 25 | $850.6M | $154.8M | ||
| Q3 25 | $832.6M | $223.5M | ||
| Q2 25 | $837.2M | $268.0M | ||
| Q1 25 | $823.1M | $274.5M | ||
| Q4 24 | $893.3M | $313.1M | ||
| Q3 24 | $867.9M | $338.5M | ||
| Q2 24 | $882.0M | $406.6M | ||
| Q1 24 | $906.0M | $369.7M |
负债/权益比OFIXOPAD
| Q4 25 | — | — | ||
| Q3 25 | 0.36× | — | ||
| Q2 25 | 0.34× | — | ||
| Q1 25 | 0.34× | — | ||
| Q4 24 | 0.31× | — | ||
| Q3 24 | 0.23× | — | ||
| Q2 24 | 0.22× | — | ||
| Q1 24 | 0.21× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $27.7M | $66.8M |
| 自由现金流经营现金流 - 资本支出 | $16.8M | $65.7M |
| 自由现金流率自由现金流/营收 | 7.6% | 57.6% |
| 资本支出强度资本支出/营收 | 4.9% | 0.9% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-1.3M | — |
8季度趋势，按日历期对齐
经营现金流OFIXOPAD
| Q4 25 | $27.7M | $66.8M | ||
| Q3 25 | $12.4M | $40.0M | ||
| Q2 25 | $11.6M | $-13.5M | ||
| Q1 25 | $-18.4M | $-10.2M | ||
| Q4 24 | $23.7M | $20.8M | ||
| Q3 24 | $11.7M | $39.6M | ||
| Q2 24 | $9.0M | $-54.4M | ||
| Q1 24 | $-18.6M | $2.4M |
自由现金流OFIXOPAD
| Q4 25 | $16.8M | $65.7M | ||
| Q3 25 | $2.5M | — | ||
| Q2 25 | $4.5M | $-13.6M | ||
| Q1 25 | $-25.1M | $-11.2M | ||
| Q4 24 | $15.2M | $15.4M | ||
| Q3 24 | $6.3M | $38.7M | ||
| Q2 24 | $-360.0K | $-54.4M | ||
| Q1 24 | $-29.1M | $2.0M |
自由现金流率OFIXOPAD
| Q4 25 | 7.6% | 57.6% | ||
| Q3 25 | 1.2% | — | ||
| Q2 25 | 2.2% | -8.5% | ||
| Q1 25 | -13.0% | -7.0% | ||
| Q4 24 | 7.0% | 8.9% | ||
| Q3 24 | 3.2% | 18.6% | ||
| Q2 24 | -0.2% | -21.7% | ||
| Q1 24 | -15.4% | 0.7% |
资本支出强度OFIXOPAD
| Q4 25 | 4.9% | 0.9% | ||
| Q3 25 | 4.8% | 0.0% | ||
| Q2 25 | 3.5% | 0.1% | ||
| Q1 25 | 3.5% | 0.6% | ||
| Q4 24 | 4.0% | 3.1% | ||
| Q3 24 | 2.7% | 0.4% | ||
| Q2 24 | 4.7% | 0.0% | ||
| Q1 24 | 5.6% | 0.1% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
OFIX
| Spinal Implants Biologics And Enabling Technologies | $113.6M | 52% |
| Bone Growth Therapies | $68.3M | 31% |
| Other | $22.7M | 10% |
| IT | $5.9M | 3% |
| GB | $3.5M | 2% |
| FR | $3.5M | 2% |
| DE | $2.3M | 1% |
OPAD
暂无分部数据
